Refametinib Completed Phase 1 Trials for Drug Drug Interaction (DDI)

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01925638Effect of Ketoconazole on the Pharmacokinetics of Refametinib